Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Non Operating Income: 2023-2025

Historic Non Operating Income for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $4.1 million.

  • Upstream Bio's Non Operating Income rose 40.85% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.3 million, marking a year-over-year increase of 47.72%. This contributed to the annual value of $15.0 million for FY2024, which is 23.59% down from last year.
  • Per Upstream Bio's latest filing, its Non Operating Income stood at $4.1 million for Q3 2025, which was down 6.73% from $4.4 million recorded in Q2 2025.
  • Upstream Bio's 5-year Non Operating Income high stood at $6.3 million for Q3 2023, and its period low was $2.5 million during Q4 2023.
  • In the last 3 years, Upstream Bio's Non Operating Income had a median value of $4.1 million in 2024 and averaged $4.1 million.
  • Data for Upstream Bio's Non Operating Income shows a peak YoY increase of 103.28% (in 2024) and a maximum YoY decrease of 53.84% (in 2024) over the last 5 years.
  • Upstream Bio's Non Operating Income (Quarterly) stood at $2.5 million in 2023, then soared by 103.28% to $5.1 million in 2024, then spiked by 40.85% to $4.1 million in 2025.
  • Its Non Operating Income stands at $4.1 million for Q3 2025, versus $4.4 million for Q2 2025 and $4.7 million for Q1 2025.